Disease-modifying potential of diphenyl diselenide in an experimental osteoarthritis model
- 4 April 2024
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 710, 149885
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (82172458, 82371589)
This publication has 16 references indexed in Scilit:
- Small molecule selenium-containing compounds: Recent development and therapeutic applicationsEuropean Journal of Medicinal Chemistry, 2021
- Toxicology and pharmacology of synthetic organoselenium compounds: an updateArchives of Toxicology, 2021
- Diphenyl diselenide protects motor neurons through inhibition of microglia-mediated inflammatory injury in amyotrophic lateral sclerosisPharmacological Research, 2021
- The role of metabolism in chondrocyte dysfunction and the progression of osteoarthritisAgeing Research Reviews, 2021
- Diphenyl diselenide alleviates diabetic peripheral neuropathy in rats with streptozotocin-induced diabetes by modulating oxidative stressBiochemical Pharmacology, 2020
- Modulation of redox and insulin signaling underlie the anti-hyperglycemic and antioxidant effects of diphenyl diselenide in zebrafishFree Radical Biology and Medicine, 2020
- Nrf2/ARE pathway attenuates oxidative and apoptotic response in human osteoarthritis chondrocytes by activating ERK1/2/ELK1-P70S6K-P90RSK signaling axisFree Radical Biology and Medicine, 2018
- Characterising the Reactions of Diselenides with Reactive Oxidants Generated During Chronic InflammationFree Radical Biology and Medicine, 2016
- Toxicology and pharmacology of selenium: emphasis on synthetic organoselenium compoundsArchives of Toxicology, 2011
- The OARSI histopathology initiative – recommendations for histological assessments of osteoarthritis in the mouseOsteoarthritis and Cartilage, 2010